FREE SHIPPING ON ORDERS OVER $150

melanotic pigmentation oral Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib | Maxillofacial Plastic and Reconstructive Surgery Pigmented lesions of the oral

$20.85

Quantity
- +
Description

Genetics 211, 367417

melanotic pigmentation oral Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib | Maxillofacial Plastic and Reconstructive Surgery Pigmented lesions of the oral

RNA 3 (3), 311330

melanotic pigmentation oral Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib | Maxillofacial Plastic and Reconstructive Surgery Pigmented lesions of the oral

doi: 10.1016/j.coms.2022.10.008

melanotic pigmentation oral Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib | Maxillofacial Plastic and Reconstructive Surgery Pigmented lesions of the oral

[DOI] [PubMed] [Google Scholar] Nimptsch A., Schibur S., Schnabelrauch M., Fuchs B., Huster D., Schiller J

melanotic pigmentation oral Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib | Maxillofacial Plastic and Reconstructive Surgery Pigmented lesions of the oral

The use of L-carnitine ('levocarnitine') and short-chain acylcarnitines (acetylcarnitine and propionylcarnitine) as proprietary dietary supplements is widespread because of reports that acetylcarnitine deficiency might lead to neurologic and psychiatric diseases

melanotic pigmentation oral Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib | Maxillofacial Plastic and Reconstructive Surgery Pigmented lesions of the oral

You may also like

recommand products